These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 24122723)

  • 1. The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation.
    Hu Y; Li H; Li WH; Meng HX; Fan YZ; Li WJ; Ji YT; Zhao H; Zhang L; Jin XM; Zhang FM
    Lupus; 2013 Dec; 22(14):1455-61. PubMed ID: 24122723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.
    Härle P; Straub RH; Wiest R; Mayer A; Schölmerich J; Atzeni F; Carrabba M; Cutolo M; Sarzi-Puttini P
    Ann Rheum Dis; 2006 Jan; 65(1):51-6. PubMed ID: 15941834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis.
    Osborn TM; Verdrengh M; Stossel TP; Tarkowski A; Bokarewa M
    Arthritis Res Ther; 2008; 10(5):R117. PubMed ID: 18822171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL; Mason JC; Davies KA
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls.
    Gilboe IM; Kvien TK; Husby G
    J Rheumatol; 1999 Aug; 26(8):1694-700. PubMed ID: 10451064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raised serum level of APRIL in patients with systemic lupus erythematosus: correlations with disease activity indices.
    Hegazy M; Darwish H; Darweesh H; El-Shehaby A; Emad Y
    Clin Immunol; 2010 Apr; 135(1):118-24. PubMed ID: 20116334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased chromogranin A levels indicate sympathetic hyperactivity in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Capellino S; Lowin T; Angele P; Falk W; Grifka J; Straub RH
    J Rheumatol; 2008 Jan; 35(1):91-9. PubMed ID: 18061980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjögren's syndrome.
    Bartoloni E; Ludovini V; Alunno A; Pistola L; Bistoni O; Crinò L; Gerli R
    Lupus; 2011 Aug; 20(9):928-35. PubMed ID: 21613330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the role of Life Essential 8 in patients diagnosed with systemic lupus erythematosus and rheumatoid arthritis.
    Wang X; Bai Y; Zou X; He X; Xie X; Ru J
    Clin Rheumatol; 2024 Oct; 43(10):3105-3116. PubMed ID: 39167326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported flaring varies during the menstrual cycle in systemic lupus erythematosus compared with rheumatoid arthritis and fibromyalgia.
    Colangelo K; Haig S; Bonner A; Zelenietz C; Pope J
    Rheumatology (Oxford); 2011 Apr; 50(4):703-8. PubMed ID: 21115463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
    Bao YQ; Wang JP; Dai ZW; Mao YM; Wu J; Guo HS; Xia YR; Ye DQ
    Clin Rheumatol; 2020 Jan; 39(1):281-290. PubMed ID: 31523787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperprolactinemia in systemic lupus erythematosus.
    Huang CM; Chou CT
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Jan; 59(1):37-41. PubMed ID: 9134821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
    Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
    Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus.
    Soyfoo MS; Roth J; Vogl T; Pochet R; Decaux G
    J Rheumatol; 2009 Oct; 36(10):2190-4. PubMed ID: 19755614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years.
    Gilboe IM; Kvien TK; Husby G
    J Rheumatol; 2001 Feb; 28(2):266-74. PubMed ID: 11246660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
    Vogl D; Falk W; Dorner M; Schölmerich J; Straub RH
    J Rheumatol; 2003 Feb; 30(2):269-75. PubMed ID: 12563679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.